Cleared Traditional

K935414 - SM EIA TEST KIT

K935414 is an FDA 510(k) clearance for SM EIA TEST KIT, manufactured by David A. Fuccillo, Ph.D.. The device is a Class 2 Immunology device with product code LJM cleared through the Traditional 510(k) pathway after a 174-day FDA review.

K935414 · David A. Fuccillo, Ph.D. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1994
Decision
174d
Days
Class 2
Risk

K935414 is an FDA 510(k) clearance for the SM EIA TEST KIT. Classified as Antinuclear Antibody (enzyme-labeled), Antigen, Controls (product code LJM), Class II - Special Controls.

Submitted by David A. Fuccillo, Ph.D. (Washington, D.C., US). The FDA issued a Cleared decision on May 2, 1994 after a review of 174 days - an extended review cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5100 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all David A. Fuccillo, Ph.D. devices

FDA 510(k) Submission Details - K935414

510(k) Number K935414 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 09, 1993
Decision Date May 02, 1994
Days to Decision 174 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
69d slower than avg
Panel avg: 105d · This submission: 174d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJM Device Classification - Class 2, Special Controls

Product Code LJM Antinuclear Antibody (enzyme-labeled), Antigen, Controls
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - LJM Antinuclear Antibody (enzyme-labeled), Antigen, Controls

All 80
Devices cleared under the same product code (LJM) and FDA review panel - the closest regulatory comparables to K935414.
RADIAS ANA SCREEN ENZYME IMMUNOASSAY
K941509 · Bio-Rad · Jun 1994
ENA SCREEN ELISA TEST SYSTEM
K941014 · Zeus Scientific, Inc. · Jun 1994
ENA PROFILE-6 ELISA TEST SYSTEM
K941409 · Zeus Scientific, Inc. · Jun 1994
SYNELISA ANA TOTAL
K935468 · Elias U.S.A., Inc. · Mar 1994
ELIAS ANA TOTAL
K940641 · Elias U.S.A., Inc. · Mar 1994
AUTOANTIBODY PROFILE-6 ELISA TEST SYSTEM
K933267 · Zeus Scientific, Inc. · Dec 1993